Clinical trial

HEC169096 in Participants With Advanced Solid Tumors

NCT05451602

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-10-21

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2022-10-21Date precision: day

Registry last updated2026-04-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumorunresolved

Interventions

HEC169096DRUG

Sponsors & collaborators

Sunshine Lake Pharma Co., Ltd.lead sponsor

Mapped research locations

GuangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05451602 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.